Biovaxys Announces Major Research Collaboration With The Ohio State University To Develop Broadly Reactive Pan-Sarbecovirus Vaccine

VANCOUVER, BC, Dec. 7, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ('BioVaxys' or 'Company'), a

Related Keywords

Beijing ,China ,Tokyo ,Japan ,Ohio ,United States ,Canada ,Ohio State University ,Vancouver ,British Columbia ,Canadian ,Gina Cestari ,Qiuhong Wang ,Kenneth Kovan ,Environmental Sciences ,Department Of Animal Sciences ,Department Of Veterinary Preventative Medicine At Ohio ,College Of Wisconsin ,Biovaxys Technology Corp ,Ohio State Wexner Medical Center ,University Of Tokyo ,College Of Food ,Biovaxys Or Company ,Food Animal Health ,Biovaxys Technology ,Ohio State ,Wexner Medical Center ,Chief Operating Officer ,Associate Professor ,Animal Sciences ,Veterinary Preventative Medicine ,Beijing Medical University ,Medical College ,Vaxys Technology ,Statements Regarding Forward Looking Information ,